Medical/Pharmaceuticals

SINOMED® Concludes Enrollment of the PIONEER III Randomized, Pivotal Study of the BuMA Supreme® Coronary Drug-Eluting Stent

TIANJIN, China, July 23, 2019 /PRNewswire/ -- In a significant milestone toward obtaining key regulatory approvals for the BuMA Supreme Drug-Eluting Stent (DES) System, SINOMED has completed enrollment in the PIONEER III randomized, controlled clinical trial.  The PIONEER III trial is designed to...

2019-07-23 15:00 130

Huge CPhI & P-MEC China a direct result of surging manufacturing

SHANGHAI, July 23, 2019 /PRNewswire/ -- CPhI and P-MEC China – organized by China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE), Informa Markets, andShanghai Sinoexpo Informa Markets – saw record numbers of attendees as the pharma market inChina continues to gr...

2019-07-23 13:18 147

WuXi STA Shanghai & Changzhou Facilities Pass U.S. FDA Inspections

SHANGHAI, July 23, 2019 /PRNewswire/ -- STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – announces that its Analytical Service Unit (ASU) inShanghai and active pharmaceutical ingredient (API) process R&D and manufacturing facility in Changzhou, have successfully passed two...

2019-07-23 12:48 199

Shinsung TK Paves Way for IoT Healthcare in Asia

SEOUL, South Korea, July 23, 2019 /PRNewswire/ -- Shinsung TK, a Korean company specializing in security system based on IoT (Internet of Things) technology, has become very active in the global market in the recent years. Recently, the company was acknowledged with its technology and reliability...

2019-07-23 12:00 192

Dermatix(R) Unveils New Product Breakthrough for Acne Scarring Solution

KUALA LUMPUR, Malaysia, July 23, 2019 /PRNewswire/ -- Dermatix ®, a brand of A.Menarini Singapore Pte.Ltd has just launched its new acne scar care, Dermatix® Acne Scar. Formulating with Niacinamide (Vitamin B3), Alpha Hydroxy Acids (AHAs) and antioxidants, it delivers a...

2019-07-23 10:00 222

Yisheng Biopharma Receives GMP Certification from China NMPA for Production of Lyophilized Rabies Vaccine for Preventive Use

BEIJING, July 22, 2019 /PRNewswire/ -- Yisheng Biopharma Co., Ltd. ("Yisheng Biopharma"), a biopharmaceutical company focusing on research, development, manufacturing, sales and marketing of immunological biologics and vaccines, announced that its new rabies vaccine production facility has receiv...

2019-07-22 21:00 341

CStone receives approval in China to initiate ivosidenib Phase I bridging registrational study for the treatment of IDH1 mutant relapsed or refractory AML

SUZHOU, China, July 22, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone"; HKEX: 2616) announced today that it has received approval from China National Medical Products Administration (NMPA) to initiate a Phase I bridging registrational study of ivosidenib (TIBSOVO) for the treatment of rela...

2019-07-22 12:17 1252

Kazia to test GDC-0084 with Radiotherapy in Phase I Clinical Trial at Leading US Cancer Center

SYDNEY, July 22, 2019 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that Memorial Sloan Kettering Cancer Center (MSK) inNew York, NY will investigate the potential use of Kazia's investigational ne...

2019-07-22 09:08 670

2019 World Brain Day Takes Aim at Migraine

Join the World Federation of Neurology on July 22 to share "The Painful Truth" about migraine LONDON, July 22, 2019 /PRNewswire/ -- This year on World Brain Day, the World Federation of Neurology (WFN) is raising awareness for migraine, one of the leading causes of global disability. United unde...

2019-07-22 07:22 483

Ascentage Pharma to Initiate Phase Ib Study of HQP1351 in Tyrosine Kinase Inhibitors -resistant Chronic Myeloid Leukemia Patients in the US

SUZHOU, China and ROCKVILLE, Md., July 22, 2019 /PRNewswire/ -- Ascentage Pharma, a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, hepatitis B virus and age-related diseases, today announced that the company was notified by the U.S. Food ...

2019-07-22 07:00 483

BETADINE(R) Celebrates the Golden Jubilee of the First Moon Landing

SINGAPORE, July 19, 2019 /PRNewswire/ -- Across the globe, BETADINE® commemorates the 50th anniversary of the Apollo 11 moon landing and its honourable connection to the inaugural manned lunar mission that placed the first humans on the surface of the moon and back to earth. As the world celebra...

2019-07-19 17:44 964

Celltrion and Nan Fung Group to establish Vcell Healthcare Limited to Develop and Commercialize Biosimilars in China

INCHEON, South Korea and HONG KONG, July 19, 2019 /PRNewswire/ -- Celltrion and Nan Fung Group announced today the establishment of Vcell Healthcare Limited, a Joint Venture company between both parties. At the formation of the Joint Venture, Vcell Healthcare Limited has simultaneously signed a ...

2019-07-19 08:00 1111

Adoption of Service-based Model Spurs Growth in the Global Medical Imaging Industry

Partnerships will be critical to achieve operational and financial excellence, finds Frost & Sullivan LONDON, July 19, 2019 /PRNewswire/ -- With healthcare systems around the world gradually transitioning to value-based care, the$250 billion global medical imaging industry is shifting from its t...

2019-07-19 00:41 1089

Merck and Broad Institute Announce CRISPR License Framework to Encourage Innovation

- New framework simplifies and accelerates access to CRISPR intellectual property for research DARMSTADT, Germany, July 18, 2019 /PRNewswire/ -- Merck, a leading science and technology company, and the Broad Institute ofMIT and Harvard (Boston, Massachusetts) today announced an agreement to offe...

2019-07-18 20:00 989

Janssen Korea Ltd. and Johnson & Johnson Innovation Announce Launch of Seoul Innovation QuickFire Challenge in Smart Healthcare in Collaboration with Seoul Metropolitan Government and Korea Health Industry Development Institute

- QuickFire Challenge seeks to identify and accelerate game-changing, early-stage health tech innovations from around the world. - Awardees will receive up to KRW150,000,000 (approximately US $134,000), residence at the Seoul Bio Hub, mentorship and coaching, and access to the Johnson & Johnson...

2019-07-18 07:00 2438

AAIC® 2019 Highlights New Research Showing Healthy Lifestyle May Offset Environmental and Genetic Risk of Alzheimer's Disease

International Conference Also Included Expert Discussion on Role of Infectious Agents in Alzheimer's Disease, and Advances Towards a Blood Test LOS ANGELES, July 18, 2019 /PRNewswire/ -- Research presented at the Alzheimer's Association International Conference (AAIC) 2019 in Los Angeles suggest...

2019-07-18 05:16 1258

Yuyu Pharma Receives Recognition for Outstanding Company Culture in Korea

SEOUL, South Korea, July 17, 2019 /PRNewswire/ -- Yuyu Pharma has received recognition as a Great Place to Work from the mayor of Jechoen city. The company also supported a recent HeForShe movement sponsored by the city of Jechoen. HeforShe is an UN-led gender equality movement that focuses on th...

2019-07-17 21:00 1132

Buyer delegations Metronic, J&J, Stryker are attending Medtec China 2019, 3 international pavilions bringing cutting-edge products

SHANGHAI, July 17, 2019 /PRNewswire/ -- Medtec China 2019 will be held from 25th - 27th September in Shanghai. The show will attract more than 25,000 professional visitors, including decision-makers, purchasers, R&D engineers, product engineers and quality inspectors from numerous, famous Chinese ...

2019-07-17 09:00 879

Menarini Silicon Biosystems Launches VRNxT Volume Reduction Instrument

BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., July 17, 2019 /PRNewswire/ -- Menarini Silicon Biosystems, the pioneer of liquid biopsy and rare cell technologies, announced that it will launch the new VRNxT(TM), a volume reduction instrument optimized to remove manual sample volume reduction steps i...

2019-07-17 08:15 1109

AirXpanders® Announces Reduction in Force and Plan to Cease Operations

SAN JOSE, California, July 17, 2019 /PRNewswire/ -- AirXpanders, Inc. (ASX: AXP), a medical device company focused on the design, manufacture, sale and distribution of the AeroForm® Tissue Expander System, today announced that the Company has reduced its workforce and plans to cease operations. ...

2019-07-17 07:17 5661
12345 ... 333